Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Non-Current Deferred Tax Liability: 2022-2024

  • Innoviva's Non-Current Deferred Tax Liability fell 29.40% to $3.8 million in Q1 2024 from the same period last year, while for Mar 2024 it was $3.8 million, marking a year-over-year decrease of 29.40%. This contributed to the annual value of $563,000 for FY2023, which is 90.24% down from last year.
  • Innoviva's Non-Current Deferred Tax Liability amounted to $3.8 million in Q1 2024, which was up 576.20% from $563,000 recorded in Q4 2023.
  • Over the past 5 years, Innoviva's Non-Current Deferred Tax Liability peaked at $5.8 million during Q4 2022, and registered a low of $360,000 during Q3 2022.
  • In the last 3 years, Innoviva's Non-Current Deferred Tax Liability had a median value of $3.8 million in 2024 and averaged $3.2 million.
  • Data for Innoviva's Non-Current Deferred Tax Liability shows a maximum YoY plummeted of 90.24% (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Innoviva's Non-Current Deferred Tax Liability stood at $5.8 million in 2022, then tumbled by 90.24% to $563,000 in 2023, then fell by 29.40% to $3.8 million in 2024.
  • Its Non-Current Deferred Tax Liability stands at $3.8 million for Q1 2024, versus $563,000 for Q4 2023 and $5.4 million for Q1 2023.